NO20053612L - 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders - Google Patents

1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders

Info

Publication number
NO20053612L
NO20053612L NO20053612A NO20053612A NO20053612L NO 20053612 L NO20053612 L NO 20053612L NO 20053612 A NO20053612 A NO 20053612A NO 20053612 A NO20053612 A NO 20053612A NO 20053612 L NO20053612 L NO 20053612L
Authority
NO
Norway
Prior art keywords
treatment
nervous system
central nervous
system disorders
derivatives useful
Prior art date
Application number
NO20053612A
Other languages
Norwegian (no)
Other versions
NO20053612D0 (en
Inventor
Mario Rottlander
Morten Bang Norgaard
Christian Wenzel Tornoe
Andreas Ritzen
Nikolay Khanzhin
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053612(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20053612D0 publication Critical patent/NO20053612D0/en
Publication of NO20053612L publication Critical patent/NO20053612L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører 1,2,4-triaminobenzenderivater med den generelle formel I eller farmasøytisk akseptable salter derav og anvendelsen derav.The present invention relates to 1,2,4-triaminobenzene derivatives of the general formula I or pharmaceutically acceptable salts thereof and the use thereof.

NO20053612A 2002-12-27 2005-07-25 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders NO20053612L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number Publication Date
NO20053612D0 NO20053612D0 (en) 2005-07-25
NO20053612L true NO20053612L (en) 2005-09-23

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053612A NO20053612L (en) 2002-12-27 2005-07-25 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders

Country Status (16)

Country Link
KR (1) KR20050089862A (en)
CN (1) CN100448867C (en)
AR (1) AR042656A1 (en)
BR (1) BR0317748A (en)
CL (1) CL2003002748A1 (en)
EA (1) EA008589B1 (en)
IS (1) IS2649B (en)
MY (1) MY139844A (en)
NO (1) NO20053612L (en)
PE (1) PE20041015A1 (en)
PL (1) PL377221A1 (en)
SI (1) SI1578740T1 (en)
TW (1) TWI325414B (en)
UA (1) UA79666C2 (en)
UY (1) UY28151A1 (en)
ZA (1) ZA200504565B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (en) * 1992-01-08 1993-07-15 Asta Medica Ag NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE19539861A1 (en) * 1995-10-26 1997-04-30 Asta Medica Ag Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
SI1578740T1 (en) 2007-08-31
CL2003002748A1 (en) 2005-04-08
UA79666C2 (en) 2007-07-10
AR042656A1 (en) 2005-06-29
BR0317748A (en) 2005-11-22
TW200413280A (en) 2004-08-01
EA200501053A1 (en) 2005-12-29
MY139844A (en) 2009-11-30
CN100448867C (en) 2009-01-07
ZA200504565B (en) 2006-08-30
CN1732162A (en) 2006-02-08
NO20053612D0 (en) 2005-07-25
TWI325414B (en) 2010-06-01
IS2649B (en) 2010-08-15
EA008589B1 (en) 2007-06-29
KR20050089862A (en) 2005-09-08
PL377221A1 (en) 2006-01-23
UY28151A1 (en) 2004-07-30
IS7856A (en) 2005-05-23
PE20041015A1 (en) 2005-01-08
HK1088317A1 (en) 2006-11-03

Similar Documents

Publication Publication Date Title
CY1106645T1 (en) 1,2,4 TRIAMINOBENZENE DERIVATIVES USEFUL FOR THE THERAPEUTIC TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
NO20044501L (en) [1,4] diazenino [6,7,1-IJ] quinoline derivatives such as antipsychotics and antidepressants
NO20073465L (en) Benzothiazole derivatives
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
NO20054848L (en) Substituted p-diaminobenzene derivatives
NO20021328L (en) Pyrazolopyrimidia as therapeutic agents
CY1109558T1 (en) Benzo derivative [D] AZEPINIS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
PT1147110E (en) PIRAZINE (AZA) -INDOL DERIVATIVES
NO20050851L (en) Caspase Inhibitors and Uses thereof
ATE524169T1 (en) THERAPEUTIC STRATEGIES FOR THE PREVENTION AND TREATMENT OF ALZEHEIMER'S DISEASE
NO20064599L (en) Substituted morpholine and thiomorpholine derivatives
NO20030724L (en) Use of derivatives of valproic acid amides and 2 valproic acid amides for the therapy or prevention of pain and / or headache disorders
FI965021A0 (en) Benzimidazole derivatives with dopaminergic effect on central nervous system
MXPA05004621A (en) Anilinopyrazole derivatives useful for the treatment of diabetes.
NO20060020L (en) 3-fluoropiperidines as NMDA / NR2B antagonists
ATE389655T1 (en) PYRIMIDINE DERIVATIVES
NO20052698L (en) 4 (phenylpiperazinylmethyl) benzamide derivatives and their use in the treatment of pain and gaseous tract disorders.
FI970469A0 (en) Benzimidazole derivatives with dopaminergic activity
MXPA05004273A (en) Phenylalkyl and pyridylalkyl piperazine derivatives.
NO20052699L (en) 4 (phenylpiperazinylmethyl) benzamide derivatives and their use in the treatment of pain and gastrointestinal disorders.
NO20071466L (en) 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogues as inhibitors of casein kinase IU
NO20062599L (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
NO20054721L (en) Substituted aniline derivatives
DE60204882D1 (en) ZYKLOALKENYLSULFONAMIDDERIVATE
DE502004007387D1 (en) TRIAZONE COMPOUNDS AND ITS THERAPEUTIC USE

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application